Delivery Order SPE2DB24D2013-SPE2DB25FCJTM
- Not listed
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $26,024.03 by the Defense Logistics Agency on September 18, 2025, for the supply of Jardiance 10 mg tablets in a 90-count quantity. The contract is non-set-aside and utilizes firm fixed pricing under a competitive delivery order arrangement, with an ultimate completion date of September 19, 2025. This award falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- AmerisourceBergen Drug Corp was awarded a delivery order on July 31, 2025, by the Defense Logistics Agency for the supply of Jardiance 10 mg tablets (90-count units) with a contract value of $2,009.06. This is a firm fixed-price delivery order with an ultimate completion date of August 1, 2025, and is being performed at the company's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation. This delivery order is issued...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on September 17, 2025, for the supply of Jardiance 25 mg tablets (90-count packages) with a ceiling value of $13,445.35. The award is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 18, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a pharmaceutical supply requirement within...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on September 4, 2025, for the supply of Jardiance 25 mg tablets in a quantity of 90 units. The contract is valued at $8,003.61 and represents a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. Performance will be completed at the vendor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 5, 2025....
- The Defense Logistics Agency awarded a delivery order valued at $15,404.48 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count units) on July 31, 2025, with an ultimate completion date of August 1, 2025. This non-competitive delivery order utilizes firm fixed pricing and is sourced from AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement to support federal healthcare operations....
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency valued at $8,158.93 on August 21, 2025, for the supply of Jardiance 25 mg tablets (90 count). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 22, 2025, and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply agreement. The company serves as a critical vendor for federal medical...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on July 21, 2025, for the supply of Jardiance 10 mg tablets in a 90-count package, with a ceiling value of $3,332.47. This non-set-aside contract utilizes firm fixed price pricing and requires completion by July 22, 2025. The award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $6,350.77 by the Defense Logistics Agency (DLA) on June 16, 2025, for the supply of Jardiance 25 mg tablets (90-count packages). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of June 17, 2025. The award represents a single delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $18,630.72 by the Defense Logistics Agency (DLA) for the supply of Jardiance 25 mg tablets in quantities of 90 units. This competitively awarded, firm fixed price delivery order is scheduled for completion by August 12, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The award was issued on August 11, 2025, under a non-set-aside procurement. This delivery order...
- AmerisourceBergen Drug Corp has been awarded a delivery order by the Defense Logistics Agency (DLA) for JARDIANCE 10 mg tablets in a 90-count package, valued at $2,457.79 with a firm fixed price structure. The award was made on July 8, 2025, with an ultimate completion date of July 9, 2025, and performance will be executed at the company's Corporate Office location in Conshohocken, Pennsylvania. This is a non-set-aside competitive award issued as a child contract under DLA procurement authority....
- SPE2DB24D2013Indefinite Delivery Contract
- SPE2DB24D2013-SPE2DB25FCJTMDelivery Order
AmerisourceBergen Drug Corp was awarded a delivery order valued at $25,290.63 by the Defense Logistics Agency (DLA) on July 29, 2025, for the supply of Jardiance 10 mg tablets (90-count). The contract is a firm fixed price delivery order with an ultimate completion date of July 30, 2025, and will be fulfilled from the company's facility in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting the Defense Health Agency and other military and veteran healthcare systems. The company's extensive portfolio of federal contract awards demonstrates its capability to supply brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The DLA maintains multiple pharmaceutical prime vendor contracts to support diverse military healthcare requirements, and AmerisourceBergen Drug Corp's significant contract value and global reach position it as a key supplier within the Defense Health Agency's medical supply chain infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $25.3k | 7/29/25 |